0001179110-15-015176.txt : 20151119
0001179110-15-015176.hdr.sgml : 20151119
20151119180317
ACCESSION NUMBER: 0001179110-15-015176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151117
FILED AS OF DATE: 20151119
DATE AS OF CHANGE: 20151119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gollust Keith R
CENTRAL INDEX KEY: 0001325712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 151244590
MAIL ADDRESS:
STREET 1: C/O SYNTA PHARMACEUTICALS CORP.
STREET 2: 45 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
edgar.xml
FORM 4 -
X0306
4
2015-11-17
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001325712
Gollust Keith R
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON
MA
02421
1
0
0
0
Common Stock
2015-11-17
4
S
0
100000
0.4140
D
2885061
I
By Wyandanch Partners, L.P.
Common Stock
401764
D
Common Stock
175000
I
By Keith R. Gollust IRA
This transaction was executed in multiple trades at prices ranging from $0.4005 to $0.4306 per share. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Garrett Winslow, Attorney-in-Fact
2015-11-19